首页> 外文期刊>Analytical and Bioanalytical Chemistry >Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS
【24h】

Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS

机译:通过UHPLC / DAD / MSMS定量分析腹膜透析液中的六种主要α-二羰基污染物

获取原文
获取原文并翻译 | 示例
           

摘要

During heat sterilization of peritoneal dialysis solutions, glucose is partially transformed into glucose degradation products (GDPs), which significantly reduce the biocompatibility of these medicinal products. Targeted α-dicarbonyl screening identified glyoxal, methylglyoxal, 3-deoxyglucosone, 3,4-dideooxyglucosone-3-ene, glucosone, and 3-deoxygalactosone as the major six GDPs with α-dicarbonyl structure. In the present study, an ultra-high-performance liquid chromatography method was developed which allows the separation of all relevant α-dicarbonyl GDPs within a run time of 15 min after derivatization with o-phenylenediamine. Hyphenated diode array detection/tandem mass spectrometry detection provides very robust quantification and, at the same time, unequivocal peak confirmation. Systematic evaluation of the derivatization process resulted in an optimal derivatization period that provided maximal derivatization yield, minimal de novo formation (uncertainty range ±5%), and maximal sample throughput. The limit of detection of the method ranged from 0.13 to 0.19 μM and the limit of quantification from 0.40 to 0.57 μM. Relative standard deviations were below 5%, and recovery rates ranged between 91% and 154%, dependent on the type and concentration of the analyte (in 87 out of 90 samples, recovery rates were 100 ± 15%). The method was then applied for the analysis of commercial peritoneal dialysis fluids (nine different product types, samples from three lots of each).
机译:在腹膜透析液的热灭菌过程中,葡萄糖被部分转化为葡萄糖降解产物(GDPs),这会大大降低这些药物的生物相容性。有针对性的α-二羰基筛选确定乙二醛结构为主要的六个GDP,其中乙二醛,甲基乙二醛,3-脱氧葡糖酮,3,4-二脱氧葡糖酮-3-烯,葡糖酮和3-脱氧半内酯。在本研究中,开发了一种超高效液相色谱方法,该方法可在邻苯二胺衍生化后的15分钟内,分离所有相关的α-二羰基GDP。联用二极管阵列检测/串联质谱检测提供了非常可靠的定量,同时还提供了明确的峰确认。对衍生化过程的系统评估导致了最佳的衍生化时期,该时期提供了最大的衍生化产率,最小的从头形成(不确定性范围为±5%)和最大的样品通量。该方法的检出限为0.13至0.19μM,定量限为0.40至0.57μM。相对标准偏差低于5%,并且回收率介于91%和154%之间,具体取决于分析物的类型和浓度(在90个样品中的87个样品中,回收率为100±15%)。然后将该方法用于分析商业腹膜透析液(九种不同的产品类型,每种来自三批样品)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号